SANA BIOTECHNOLOGY INC (SANA) Stock Balance Sheet
NASDAQ:SANA - Nasdaq - US7995661045 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 127.00M | 133.52M | 176.80M | 253.00M | 124.80M | |||
| Marketable Securities | 72.01M | 71.68M | 247.20M | 298.00M | 253.50M | |||
| Other Current Assets | 11.14M | 8.32M | 20.50M | 7.10M | 6.20M | |||
| Total Current Assets | 210.15M | 213.51M | 444.40M | 558.10M | 384.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 143.87M | 145.59M | 159.40M | 161.80M | 109.90M | |||
| Investments And Advances | N/A | 0.00 | 10.10M | 195.90M | 33.70M | |||
| Goodwill | 140.63M | 140.63M | 140.60M | 140.60M | 140.60M | |||
| Intangibles | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | |||
| Other Non-Current Assets | 5.55M | 6.37M | 9.00M | 13.80M | 2.30M | |||
| Total Non-Current Assets | 349.24M | 351.78M | 378.30M | 571.30M | 345.80M | |||
| TOTAL ASSETS | 559.39M | 565.30M | 822.70M | 1.13B | 730.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 40.31M | 57.70M | 50.40M | 38.20M | 25.50M | |||
| Accounts Payable | 2.99M | 4.11M | 2.90M | 2.20M | 2.30M | |||
| Other Current Liabilities | 3.71M | 2.68M | 58.20M | 58.80M | 3.70M | |||
| Total Current Liabilities | 47.00M | 64.49M | 111.50M | 99.20M | 31.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 219.91M | 213.31M | 211.90M | 301.70M | 267.10M | |||
| Total Non-Current Liabilities | 219.91M | 213.31M | 211.90M | 301.70M | 267.10M | |||
| TOTAL LIABILITIES | 266.91M | 277.79M | 323.40M | 400.90M | 298.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.56B | -1.34B | -1.05B | -785.40M | -429.40M | |||
| Additional Paid In Capital | 1.85B | 1.63B | 1.56B | 1.52B | 8.20M | |||
| Common Shares | 22.00K | 20.00K | 0.00 | 0.00 | 852.90M | |||
| Other Shareholders' Equity | 54.00K | -60.00K | -4.30M | -1.40M | 0.00 | |||
| Shares Outstanding | 223.11M | 197.86M | 191.00M | 184.90M | 183.80M | |||
| Tangible Book Value per Share | 0.42 | 0.44 | 1.57 | 2.86 | -3.38 | |||
| Total Shareholders' Equity | 292.48M | 287.51M | 499.30M | 728.50M | 431.70M | |||
| TOTAL LIABILITIES AND EQUITY | 559.39M | 565.30M | 822.70M | 1.13B | 730.30M | |||
| Statistics | ||||||||
| Current Ratio | 4.47 | 3.31 | 3.99 | 5.63 | 12.21 | |||
| Return On Assets (ROA) | -54.67% | -50.11% | -32.76% | -31.51% | -39.07% | |||
| Return On Equity (ROE) | -104.56% | -98.52% | -53.97% | -48.86% | -66.09% | |||
All data in USD , ROIC based on taxRate of 0.21